Podcasts

Using antipsychotics for dementia

Current Psychiatry. 2017 December;16(12)
By
Helen C. Kales, MD
Author and Disclosure Information

Helen C. Kales, MD, discusses risks and benefits of antipsychotics and other psychotropics for behavioral and psychological symptoms of dementia.

 

Recommended Reading

VIDEO: Alzheimer’s blood test expected soon
MDedge Psychiatry
Driving ability of Parkinson’s patients can decline quickly
MDedge Psychiatry
Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentum
MDedge Psychiatry
Aducanumab continues to rack up positive numbers in phase 1b open-label extension
MDedge Psychiatry
New BACE1 study launches in the shadow of verubecestat’s demise
MDedge Psychiatry
Amyloid imaging changed management for 80% of patients with uncertain dementia diagnosis
MDedge Psychiatry
Pimavanserin found modestly effective in phase 2 Alzheimer’s psychosis study
MDedge Psychiatry
Long-term cholinesterase inhibition may slow cognitive decline – and more
MDedge Psychiatry
MACRA Monday: Elder maltreatment screening
MDedge Psychiatry
Intepirdine flops in phase 3 study of mild to moderate Alzheimer’s patients
MDedge Psychiatry